AN ACT CONCERNING THE COST OF PRESCRIPTION DRUGS AND VALUE-BASED INSURANCE DESIGN.
To: (1) Require manufacturers of prescription drugs to disclose pricing information to the Insurance Commissioner; (2) require that certain insurance policies incorporate value-based insurance design; and (3) establish a task force to study methods of controlling the cost of prescription drugs.
Introduced by:Insurance and Real Estate Committee
|New today||2-4 days old||5 days & older|
Co-sponsors for Amendment LCO:
|3/30/2017||(LCO)||File Number 345|
|3/30/2017||House Calendar Number 252|
|3/30/2017||Tabled for the Calendar, House|
|3/30/2017||Favorable Report, House Committee on Insurance and Real Estate|
|3/30/2017||(LCO)||Reported Out of Legislative Commissioners' Office|
|3/24/2017||(LCO)||Referred to Office of Legislative Research and Office of Fiscal Analysis 03/29/17 5:00 PM|
|3/16/2017||(LCO)||Filed with Legislative Commissioners' Office|
|3/15/2017||(INS)||House Favorable Substitute|
|3/15/2017||(INS)||Motion Failed SF|
|3/3/2017||Public Hearing 03/07|
|2/24/2017||Referred to Joint Committee on Insurance and Real Estate|